Clinical Trials in the Netherlands / NCT06692374
Starting soon Observational

Automated Cardiac Arrest Detection and Alerting in Daily Life

NCT06692374 · tracked via the Priya Life Science Netherlands tracker
Phase
Observational
Started
2025-01-01
Last updated
2024-11-18

Condition(s) studied

Cardiac Arrest (CA)Sudden Death, Cardiac

Study summary

Surviving a cardiac arrest that happens outside the hospital depends on quickly recognizing the event and immediately starting CPR. Survival rates have improved when cardiac arrest is witnessed, but when it isn't, help often arrives too late. Wearable biosensors, like special wristbands, could detect cardiac arrest automatically and alert emergency responders, providing faster help.

In the already finished DETECT-1 study, the investigators developed a system that uses wrist-worn sensors to identify cardiac arrest. The goal of the current study is to test how well this system works in people who have an implantable cardioverter defibrillator (ICD). An ICD is a device that monitors and treats dangerous heart rhythms. Study participants will wear a medical wristband with sensors that monitor the heartrate and movement during their daily activities to see if the system accurately detects cardiac arrest.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with an implantable cardioverter defibrillator (ICD) * Age 18 years or older * Fitting the wristband * In possession of a smartphone that is compatible with the wristband Exclusion Criteria: * Known hemodynamically relevant bilateral subclavian artery stenosis * Medical issues that interfere with wearing of the wristband (e.g. skin disorders) * Insufficient skills to operate with the device/app

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
RadboudUMC Nijmegen Gelderland

More Radboud University Medical Center trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06692374 on ClinicalTrials.gov ↗ ← All trials in the Netherlands